SAMUEL WALING: Open Payments
NPI 1053774018 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 50 payments from 11 companies in 2025. Trend: 2023 $708 · 2024 $154 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $207 |
| Lilly USA, LLC | 6 | $119 |
| PFIZER INC. | 3 | $80 |
| Exact Sciences Corporation | 4 | $78 |
| Abbott Laboratories | 3 | $67 |
| Dexcom, Inc. | 2 | $56 |
| Amgen Inc. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| IBSA Pharma Inc. | 1 | $23 |
Products named: Ozempic, MOUNJARO, The Cologuard Plus Collection Kit, FREESTYLE LIBRE 3, Wegovy, Dexcom G6 Transmitter, NURTEC ODT, REPATHA.
Industry payments across AL — which companies pay providers there.
